Clear 489 Results Filter Filter Results Type: Press Release New Study Finds Abiomed Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention Type: Press Release Abiomed Surpasses 50000 Impella® Patients Treated in the United States Type: Press Release Abiomed Celebrates 2017 American Heart Month Type: Press Release Abiomed Announces Q3 FY 2017 Revenue of $1147 Million Up 34% Over Prior Year Type: Press Release Abiomed Announces Preliminary Q3 FY 2017 Revenue of $1147 Million Up 34% Over Prior Year Type: Press Release Abiomed Third Quarter Fiscal 2017 Earnings and Conference Call Notification Type: Press Release Abiomed to Present at the 35th Annual JP Morgan Healthcare Conference Type: Press Release Abiomed Impella CP Receives Expanded FDA Approval for High-Risk Percutaneous Coronary Intervention (PCI) Procedures Type: Press Release Abiomed Launches Impella Quality (IQ) Assurance Program and Shares Insight From Largest Database of Real-World Evidence of High-Risk PCI and Cardiogenic Shock Patients Type: Press Release Abiomed Receives FDA IDE Approval for Initiation of Door to Unloading (DTU) Prospective Feasibility Study … 8 9 10 11 …
